Inspira Technologies Oxy B.H.N. Ltd. (IINN) has released an update.
Inspira Technologies Oxy B.H.N. Ltd., a medical technology firm, announced receiving the CSA Certification of Compliance to U.S. standards for its INSPIRA ART100 device, signifying a leap towards U.S. market access pending FDA approval. The certification marks the device’s adherence to safety and performance requirements, reflecting the company’s dedication to high-quality and safe medical products. Inspira Technologies specializes in innovative respiratory treatment technologies that aim to offer safer and less invasive alternatives to traditional mechanical ventilation.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
